Effectiveness of Dry Needling Adjuvant to Selective Serotonin Reputake Inhibitors vs TP Injection for Pain Management

Effectiveness of Dry Needling Adjuvant to Selective Serotonin Reputake Inhibitors Versus Trigger Point Injection for Pain Management in Fibromyalgia

The principal objective is to contribute valuable insights that hold direct implications for medical practice and patient care, with the potential to influence health policy pertaining to fibromyalgia management.

The study aims to outline distinct patient subgroups manifesting heightened responsiveness to one therapeutic intervention vis-à-vis the other, thereby facilitating the formulation of more personalized and efficacious treatment modalities.

Inclusion Criteria:

• Stable on SSRIs for at least three months (for Group A)
• Age between 18 and 65 years
• Participants suffering from recent cervical pain without any pathology

Exclusion Criteria:

• Presence of any other chronic pain conditions.
• Contraindications to SSRIs or trigger point injections.
• Pregnancy or lactation.
• History of psychiatric disorders other than depression and anxiety